---
$id: https://graph.org.ai/products/commodity/51111771
$type: Product
source: UNSPSC
code: "51111771"
title: "Vinleucinol"
class: "51111700"
classTitle: "Antineoplastic antibiotics"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Vinleucinol

**UNSPSC Code**: 51111771
**Class**: [Antineoplastic antibiotics](Antineoplastic antibiotics.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a vinca alkaloid compound with the molecular formula C51H69N5O9, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier MUJ5BW9BWR, chemically known as vincaleukoblastine, o(sup 4)-deacetyl-3-de(methoxycarbonyl)-3-(((1-(ethoxycarbonyl)-2-methylbutyl)amino)carbonyl)-, (3(1s,2s))- but generally known as vinleucinol, which bears US NIH Compound Identifier 72163. European Medicines Agency schedules Vinleucinol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00067MIG. The term VINLEUCINOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 5, No. 3 1991, List 31). VINLEUCINOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule vinleucinol under HS 29399900 and SITC 54149. As of Q4 2014, VINLEUCINOL remains the US FDA Preferred Term for this commodity. Vinleucinol bears US NLM identifiers UMLS ID C0247144 and NCI Concept Code C95239. SMILES: OC1(C2N(C3C(C42C2N(CC4)CC=CC2(C1O)CC)CC(C(OC)C3)C1(CC2CC(O)(CN(C2)CCC2C1[NH]C1C2CCCC1)CC)C(=O)OC)C)C(=O)NC(C(CC)C)C(=O)OCC.

